Akamis Bio to Present Initial Data from the Phase 1b FORTRESS Study of NG-350A in Mismatch Repair-Proficient Locally Advanced Rectal Cancer at AACR 2026 Company to disclose clinical safety and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results